2025
Uric Acid Stroke Cerebroprotection Transcended Sex, Age, and Comorbidities in a Multicenter Preclinical Trial
Patel R, Kumskova M, Kodali H, Budnik I, Kuznetsov V, Jain A, Jha A, Thedens D, Dhanesha N, Sutariya B, Nagarkatti K, Lamb J, Kamat P, Shi Y, Avery B, Imai T, Jin X, Chauhan A, Boisserand L, Khan M, Dhandapani K, Sanganahalli B, Sansing L, Hess D, Koehler R, McCullough L, Aronowski J, Ayata C, Diniz M, Lyden P, Planas A, Chamorro A, Chauhan A, Leira E, Investigators O. Uric Acid Stroke Cerebroprotection Transcended Sex, Age, and Comorbidities in a Multicenter Preclinical Trial. Stroke 2025, 56: 965-973. PMID: 40091742, PMCID: PMC11932773, DOI: 10.1161/strokeaha.124.048748.Peer-Reviewed Original ResearchConceptsUA-treated animalsPrimary functional outcomeFunctional outcomesMiddle cerebral artery filament occlusionModified intention-to-treat populationIntention-to-treat populationUric acidHuman clinical trialsImprove functional outcomesStudy drugIntravenous salineEffects of UARelevant to patientsClinical trialsPrimary outcomeSaline controlsSecondary outcomesPreclinical trialsDay 2Survival rateDay 7Filament occlusionGroups of animalsComorbiditiesDiverse comorbidities
2018
Disorders of Mineral Metabolism in Childhood
Carpenter T, S. N. Disorders of Mineral Metabolism in Childhood. 2018, 705-712. DOI: 10.1002/9781119266594.ch91.Peer-Reviewed Original ResearchMineral metabolismDisorders of magnesiumFocal clonic seizuresChildhood age groupAcquired hypoparathyroidismAcute hypocalcemiaLimb jerkingPersistent hypocalcemiaAcute hypercalcemiaSevere hypocalcemiaAutoimmune destructionClonic seizuresIntravenous salineEnema preparationOral administrationSkeletal manifestationsCalcium homeostasisAge groupsCongenital hypoparathyroidismHypocalcemiaDisordersPhosphate homeostasisHypoparathyroidismHour intervalsAdministration
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply